Win - Win Agreements in the Drug Industry
	SMi Conferences Ltd. , The Hatton, London 25th and 26th October
	Some of the issues that will be discussed include:  Selecting The Right Partner  Selecting The Right Technology And Therapeutic Areas  Strategic Alliances And Knowledge Management  Intellectual Property Rights And Ownership Issues  Risk Management In Pharmaceutical Partnership Agreements  Co-Marketing And Co-Promotion  Patents And Licenses  Out-Licensing And The Product Life-Cycle
	Organized by:	SMi Conferences
	Invited Speakers:	SMi’s Win-Win Agreements in the Drug Industry will benefit from the support of many key experts in the field such as:  Pauline Jen Ryan, Vice President, Business Development, ImmunoGen  Dr Björn Nordenvall, President and Chief Executive Officer, OXiGENE  Dr Rivka Sherman-Gold, Director, Business Development, Abgenix  William Jack, Chief Executive Officer, Mattson Jack Group
	Deadline for Abstracts:	23rd October 2000
	Registration:	Delegate Fee: £999.00 (excluding VAT).
	Email for Requests and Registration:	customer_services@smiconferences.co.uk
	Posted by: Frances Denny   Host: 213.38.112.46 date: August 15, 2000 9:55:52 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.